These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39038837)

  • 1. Covid-19: politicisation, "corruption," and suppression of science.
    BMJ; 2024 Jul; 386():q1624. PubMed ID: 39038837
    [No Abstract]   [Full Text] [Related]  

  • 2. Covid-19: politicisation, "corruption," and suppression of science.
    Abbasi K
    BMJ; 2020 Nov; 371():m4425. PubMed ID: 33187972
    [No Abstract]   [Full Text] [Related]  

  • 3. Politicisation, depoliticisation, and repoliticisation of health care controversies: Vaccination and mental health care reform in the Czech Republic.
    Numerato D; Honová PA; Sedláčková T
    Soc Sci Med; 2021 May; 277():113916. PubMed ID: 33878664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covid-19 corruption in the public health sector-emerging evidence from Bangladesh.
    Hossain MM; Rahaman MM; Rahman MJ
    Health Policy Plan; 2023 Aug; 38(7):799-821. PubMed ID: 37243741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nagorno-Karabakh conflict and the politicisation of science.
    Babayev SN; Hajiyeva S; Baghirzada L; Ashina S; Alekberli T;
    Lancet Glob Health; 2021 Mar; 9(3):e253-e254. PubMed ID: 33607024
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of corruption and income inequality on the reported number of COVID-19 cases and deaths: Evidence from a time series cross-sectional data analysis.
    Khan AR; Abedin S; Rahman MM; Khan S
    PLOS Glob Public Health; 2022; 2(11):e0001157. PubMed ID: 36962690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health sector corruption in the times of COVID-19 pandemic in Bangladesh: Newspapers as mirrors of society.
    Khanam M; Shuchi NS; Kamal RS; Ahmed SM
    Heliyon; 2023 Dec; 9(12):e22318. PubMed ID: 38107278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review.
    Griffore KA; Bowra A; Guilcher SJT; Kohler J
    Global Health; 2023 Nov; 19(1):91. PubMed ID: 38001483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the Usual Suspects and Towards Politicisation: Immigration in Quebec's Party Manifestos, 1991-2018.
    Xhardez C; Paquet M
    J Int Migr Integr; 2021; 22(2):673-690. PubMed ID: 32837335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the COVID-19 pandemic to corrupt practices: a tale of two evils.
    Usman M; Husnain M; Akhtar MW; Ali Y; Riaz A; Riaz A
    Environ Sci Pollut Res Int; 2022 Apr; 29(20):30297-30310. PubMed ID: 35000178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing health corruption during a public health crisis through anticipatory governance: Lessons from the COVID-19 pandemic.
    Gonzalez-Aquines A; Kowalska-Bobko I
    Front Public Health; 2022; 10():952979. PubMed ID: 35968489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of Covid-19.
    Teremetskyi V; Duliba Y; Kroitor V; Korchak N; Makarenko O
    Med Leg J; 2021 Mar; 89(1):25-28. PubMed ID: 33331228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corruption, public trust and medical autonomy in the public health sector of Montenegro: Taking stock of the COVID-19 influence.
    Radević I; Alfirević N; Lojpur A
    PLoS One; 2022; 17(9):e0274318. PubMed ID: 36074759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the impact of corruption in Latin America during the spread of the first wave of COVID-19.
    Moya-Espinoza JG; Moya-Salazar J; Chicoma-Flores K
    Med Leg J; 2022 Dec; 90(4):206-211. PubMed ID: 36124417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria.
    Onwujekwe O; Orjiakor C; Ogbozor P; Agu I; Agwu P; Wright T; Balabanova D; Kohler J
    J Pharm Policy Pract; 2023 Nov; 16(1):141. PubMed ID: 37957711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobbying in the face of politicisation: interest group strategies in trade policy.
    Dür A; Mateo G
    J Eur Public Policy; 2024; 31(1):212-238. PubMed ID: 38179337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences of corruption types in selected Western and central-eastern health systems during the COVID-19 pandemic: a rapid review.
    Gonzalez-Aquines A; Cordero-Perez AC; Kowalska-Bobko I
    Front Public Health; 2023; 11():1269189. PubMed ID: 37876721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corruption in healthcare: a view from the pandemic.
    Duliba Y; Streltsov Y; Kharchenko V; Korchak N; Antonova O
    Med Leg J; 2024 Mar; 92(1):43-45. PubMed ID: 36510470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epistemic Corruption, the Pharmaceutical Industry, and the Body of Medical Science.
    Sismondo S
    Front Res Metr Anal; 2021; 6():614013. PubMed ID: 33870067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations.
    Gorodensky A; Bowra A; Saeed G; Kohler J
    BMJ Open; 2022 Dec; 12(12):e064137. PubMed ID: 36549737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.